Glenmark Pharmaceuticals informs about media release

18 Oct 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Glenmark Pharma is first to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes in Adults with Co-morbidities’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1036.15 -5.95 (-0.57%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.